Insufficient nocturnal sleep was associated with a higher risk of fibrosis in patients with diabetes with metabolic associated fatty liver disease
Background: Metabolic associated fatty liver disease (MAFLD) refers to metabolic dysfunction associated with fatty liver disease, and liver fibrosis stage is closely connected with liver-related and all-cause mortality. This study aimed to explore the association of sleep duration with liver fibrosi...
Main Authors: | Jiaping Zheng, Sijie Chen, Yuqing Cai, Su Lin, Sujie Ke, Libin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-09-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/2042018820947550 |
Similar Items
-
Association of obstructive sleep apnea with nocturnal hypoxemia in metabolic-associated fatty liver disease patients: A cross-sectional analysis of record-based
by: Arvind Tomar, et al.
Published: (2021-01-01) -
P-20 METABOLIC ASSOCIATED FATTY LIVER DISEASE: FIBROSIS AND SARCOPENIA FREQUENCIES
by: Priscila Pollo Flores, et al.
Published: (2021-09-01) -
Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease.
by: Ali Bayoumi, et al.
Published: (2020-01-01) -
Nocturnal sweating in obstructive sleep apnoea and its association with sleep parameters
by: Güray Koç, et al.
Published: (2019-03-01) -
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
by: Mayada Metwally, et al.
Published: (2021-08-01)